CAMBRIDGE, Tuesday 5 July 2022 — VP of Research Products at bit.bio Dr Farah Patell-Socha is featured in the latest issue of HealthTechWorld.
The piece looks at neurodegenerative diseases including Huntington’s, Parkinson’s and Alzheimer’s disease.
Dr Patell-Socha discusses how consistent cell models can help accelerate research and drug development for these diseases and bit.bio's recently launched product ioGlutamatergic Neurons HTT50CAG/WT - a disease model for Huntington's.
Latest news
-
News | Watch our CEO explain LifeOS and its potential in just 15 mins
-
Press release | bit.bio expands independent Ethics and Sustainability Board
-
Press release | new cell products for neurodegenerative disease
-
News | Continuing to building a sustainable business
-
Podcast | Founder/CEO Dr Mark Kotter speaking on The Genetics Podcast